[ORGANIZATION]
Landis+Gyr Group AG
Featured in 4 tracked stories · first seen
Situations
US biotechnology sector IPO activity
2 clusters · 8 sources · last updated
Latest: Landis+Gyr secures major US utility contract for 3 million meters
Biotechnology companies have begun pursuing initial public offerings (IPOs) to fund clinical development despite market uncertainty. City Therapeutics, a Massachusetts-based firm specializing in RNA-based rare disease
Also covered in
-
Landis+Gyr reports record gross margin despite revenue decline
[BUSINESS] · 4 sources ·
-
Landis+Gyr posts lower Q1 FY2026 revenue, boosts share buyback
[BUSINESS] · 4 sources ·